COVID-19 as a trigger for splenic infarction in a patient with sickle cell trait: A case report

Autor: Álvaro Alejandre-de-Oña, Jaime Alonso-Muñoz, Pablo Demelo-Rodríguez, Jorge del-Toro-Cervera, Francisco Galeano-Valle

Publikováno v: Thrombosis Update, Vol 3, Iss , Pp 100047- (2021)

Sickle cell trait (SCT) is the carrier state for sickle cell disease (SCD) and is usually perceived as a mild condition; however, previous studies have shown that hypoxemia may trigger sickle-cell related complications in these patients, including sp

Externí odkaz: https://doaj.org/article/cae7bfee8b77484c85ce13e1b3d151f3

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Autor: Luis M. Pérez-Belmonte, José David Torres-Peña, María D. López-Carmona, M. Mar. Ayala-Gutiérrez, Francisco Fuentes-Jiménez, Lucía Jorge Huerta, Jaime Alonso Muñoz, Manuel Rubio-Rivas, Manel Madrazo, Marcos Guzmán Garcia, Beatriz Vicente Montes, Joaquim Fernández Sola, Javier Ena, Ruth Gonzalez Ferrer, Carmen Mella Pérez, Carlos Jorge Ripper, Jose Javier Napal Lecumberri, Iris El Attar Acedo, Susana Plaza Canteli, Sara Fuente Cosío, Francisco Amorós Martínez, Begoña Cortés Rodríguez, Pablo Pérez-Martínez, José Manuel Ramos-Rincón, Ricardo Gómez-Huelgas, for the SEMI-COVID-19 Network

Publikováno v: BMC Medicine, Vol 18, Iss 1, Pp 1-10 (2020)

Abstract Background Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually

Externí odkaz: https://doaj.org/article/075d60a7a4074e35b070c9194fc6a79a

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Autor: Susana Plaza Canteli, Sara Fuente Cosío, Iris El Attar Acedo, Francisco Fuentes-Jiménez, Pablo Perez-Martinez, Lucía Jorge Huerta, Marcos Guzmán Garcia, Jaime Alonso Muñoz, Carlos Jorge Ripper, M. Mar. Ayala-Gutiérrez, Manuel Rubio-Rivas, Jose Javier Napal Lecumberri, José Manuel Ramos-Rincón, Jose D Torres-Peña, Ruth Gonzalez Ferrer, Joaquim Fernández Sola, Ricardo Gómez-Huelgas, Beatriz Vicente Montes, Begoña Cortés Rodríguez, Javier Ena, Luis M. Pérez-Belmonte, Manel Madrazo, Carmen Mella Pérez, Francisco Amorós Martínez, María D. López-Carmona

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
BMC MEDICINE
r-FISABIO. Repositorio Institucional de Producción Científica
INIA: Repositorio de Resultados de Investigación del INIA
RUNA. Repositorio da Consellería de Sanidade e Sergas
Servizo Galego de Saúde (SERGAS)
BMC Medicine
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
BMC Medicine, Vol 18, Iss 1, Pp 1-10 (2020)

BackgroundLimited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae05c0faf70ddb705901843cc2e6a76
http://hdl.handle.net/2445/173823

Retroperitoneal fibrosis associated with orbital pseudotumor without evidence of IgG4: A case report with review of literature

Autor: María-Teresa Pérez-Sanz, Francisco Galeano-Valle, Eva Cervilla-Muñoz, Almudena Marcelo-Ayala, Jaime Alonso-Muñoz, María-Dolores Pulfer

Retroperitoneal fibrosis (RPF) is a rare disease characterized by chronic inflammation and periaortic fibrosis that affects retroperitoneal structures and often entraps the ureters. The idiopathic form has an incidence of 0.1-1.3/100,000 person-years

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d0087cdedc576971d5d6d3978327a35
https://europepmc.org/articles/PMC6409117/

COVID-19 as a trigger for splenic infarction in a patient with sickle cell trait: A case report

Autor: Jaime Alonso-Muñoz, Jorge Del-Toro-Cervera, Francisco Galeano-Valle, Álvaro Alejandre-de-Oña, Pablo Demelo-Rodríguez

Publikováno v: Thrombosis Update
Thrombosis Update, Vol 3, Iss, Pp 100047-(2021)

Sickle cell trait (SCT) is the carrier state for sickle cell disease (SCD) and is usually perceived as a mild condition; however, previous studies have shown that hypoxemia may trigger sickle-cell related complications in these patients, including sp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31a28e8b42f5a9057bd7f8ce25203142
http://europepmc.org/articles/PMC7986315